Updating the assessment of cardiac risk: beyond Framingham

Area of Science:

• Cardiology and Public Health
• Epidemiology of Cardiovascular Diseases

Background:

• Established cardiovascular risk factors from the Framingham Heart Study have significantly reduced cardiovascular morbidity and mortality.
• The Framingham risk score is a cornerstone of current clinical risk assessment for coronary heart disease.
• Emerging risk predictors offer potential for improved patient risk identification and stratification.

Purpose of the Study:

• To review novel cardiovascular risk predictors beyond traditional Framingham factors.
• To discuss the integration of new predictors into existing cardiovascular risk assessment frameworks.
• To highlight the development of population-specific risk-scoring systems.

Main Methods:

• Review of established and novel cardiovascular risk factors.
• Analysis of emerging predictors such as lipoprotein profiles, inflammatory markers (lipoprotein-associated phospholipase A2, C-reactive protein), glycemic control, liver function, and central obesity.
• Examination of vascular imaging techniques for risk assessment.
• Discussion of international risk-scoring systems derived from the Framingham model.

Main Results:

• Novel risk predictors, including advanced lipoprotein analysis, inflammatory markers, and metabolic assessments, can refine cardiovascular risk stratification.
• Vascular imaging provides additional valuable information for risk assessment.
• International adaptations of risk-scoring systems improve population-specific accuracy.

Conclusions:

• Newer risk predictors complement the Framingham framework, enhancing the ability to identify individuals at higher cardiovascular risk.
• Integration of these predictors allows for more precise risk definition and personalized prevention strategies.
• Optimized cardiovascular risk assessment using updated predictors can lead to effective minimization or avoidance of cardiovascular disease burden.